Insider Transactions in Q2 2022 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.21%
|
$450,000
$60.49 P/Share
|
|
Jun 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
Jun 14
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-5.75%
|
-
|
|
Jun 07
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.29%
|
$350,000
$70.08 P/Share
|
|
Jun 06
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.74%
|
$2,010,000
$67.94 P/Share
|
|
Jun 06
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.92%
|
$0
$0.43 P/Share
|
|
May 27
2022
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+1.18%
|
-
|
|
May 27
2022
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+0.56%
|
-
|
|
May 27
2022
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+5.05%
|
-
|
|
May 26
2022
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+0.97%
|
-
|
|
May 26
2022
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+0.46%
|
-
|
|
May 26
2022
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+7.05%
|
-
|
|
May 26
2022
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+30.13%
|
-
|
|
May 26
2022
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+4.36%
|
-
|
|
May 26
2022
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+34.42%
|
-
|
|
May 26
2022
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+7.05%
|
-
|
|
May 26
2022
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+35.64%
|
-
|
|
May 16
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-1.78%
|
$442,500
$59.05 P/Share
|
|
May 16
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
May 10
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+21.77%
|
$0
$0.46 P/Share
|
|
May 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.28%
|
$2,250,000
$75.22 P/Share
|
|
May 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.52%
|
$0
$0.43 P/Share
|
|
May 02
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.64%
|
$395,000
$79.65 P/Share
|
|
Apr 18
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.22%
|
$652,500
$87.8 P/Share
|
|
Apr 18
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
Apr 18
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$609,000
$87.83 P/Share
|
|
Apr 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.75%
|
$2,670,000
$89.73 P/Share
|
|
Apr 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.92%
|
$0
$0.43 P/Share
|
|
Apr 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-0.14%
|
$138,600
$90.92 P/Share
|
|
Apr 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.23%
|
$910,000
$91.22 P/Share
|
|
Apr 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.3%
|
$89,370
$90.92 P/Share
|
|
Apr 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.41%
|
$59,580
$90.92 P/Share
|
|
Apr 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.43%
|
$61,200
$90.92 P/Share
|